A
ADCT
Adc Therapeutics Sa
1.440
-0.160-10.00%After Hours: 1.440 0.000 0.00%19:30 10/23 EDT
OPEN/PREV CLOSE1.580/1.600
TODAY RANGE1.430-1.585
VOL1.05M
MARKET CAP183.84M
52 WEEK RANGE0.7796-4.980
AVG VOL (3M)1.55M
% TURNOVER0.82%
TURNOVER--
P/E (TTM)-1.9805
% RANGE9.38%
EPS(TTM)-0.7271
P/E(FORWARD)-1.9136
P/B-0.8042
BVPS-1.7907
DIVIDEND--
P/S2.226
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP157.33M
SHARES OUTSTANDING127.67M
NEXT EARNINGS11/09-11/13
FREE FLOAT109.26M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·10/13 10:48
ADC Therapeutics Announces Major Financial Restructuring Initiatives
Seeking Alpha·10/09 14:06
ADC Therapeutics: Shares Spike On Restructuring, But Safety Fears Undermine Bull Thesis
TipRanks·10/09 01:45
RBC Capital Reaffirms Their Hold Rating on ADC Therapeutics (ADCT)
Seeking Alpha·10/08 15:23
ADC Therapeutics undergoes strategic financial restructuring
TipRanks·10/08 13:15
ADC Therapeutics announces comprehensive strategic financial restructuring
MarketWatch·09/21 21:06
These beaten-down stocks could bounce back in January, if history is any guide
PR Newswire·09/03 11:15
ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
TipRanks·08/25 00:11
ADC Therapeutics Balances Earnings Gains With Trial Risks
Dow Jones·08/17 13:45
ADC Therapeutics Is Maintained at Buy by Guggenheim
Dow Jones·08/17 13:45
ADC Therapeutics Price Target Cut to $5.00/Share From $10.00 by Guggenheim
Benzinga·08/17 13:41
Guggenheim Maintains Buy on ADC Therapeutics, Lowers Price Target to $5
TipRanks·08/17 11:07
ADC Therapeutics price target lowered to $5 from $10 at Guggenheim
Same Industry
Name/Symbol
Change%
Price